Andrew Whitelaw is a clinical microbiologist and the Head of Division of Medical Microbiology at the University of Stellenbosch / Tygerberg Hospital NHLS since December 2012. He has been involved in a number of studies and activities related to antibiotic resistance and infection control over the last decade, both for community as well as hospital-acquired pathogens. These include the membership of the South African Antibiotic Stewardship Programme (SAASP), being past president of the Infection Control Society of Southern Africa and serving two terms on the SA Ministerial Advisory Committee on AMR (MAC-AMR). As part of the MAC-AMR, he was a member of the Technical Working Group for Surveillance. Ongoing research interests focus on epidemiology of antimicrobial resistance, clinical impact and control of AMR and Hospital-Acquired Infections, and genomic diagnostics and surveillance.